Aethlon Medical (AEMD, Financial) is set to announce its financial results following the close of the trading session. Analysts project an earnings per share of ($1.09) for the period. Investors are keenly watching as this report will provide insights into the company’s performance and future prospects. The market's reaction will be closely observed, given the consensus expectations.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 2 analysts, the average target price for Aethlon Medical Inc (AEMD, Financial) is $30.25 with a high estimate of $56.00 and a low estimate of $4.50. The average target implies an upside of 1,628.57% from the current price of $1.75. More detailed estimate data can be found on the Aethlon Medical Inc (AEMD) Forecast page.
Based on the consensus recommendation from 2 brokerage firms, Aethlon Medical Inc's (AEMD, Financial) average brokerage recommendation is currently 2.5, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Aethlon Medical Inc (AEMD, Financial) in one year is $99.64, suggesting a upside of 5593.71% from the current price of $1.75. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Aethlon Medical Inc (AEMD) Summary page.
